menu
    • menu

    Company profile for HaemaLogiX

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The team at HaemaLogiX, together with our collaborators, is researching unique immune-based treatments to improve outcomes in patients suffering from blood cancers. The goal of these treatments is to help a patient’s immune system fight their own disease. We aim to commercialise our therapies through a series of strategic partnerships. HaemaLogiX was formed as a private Australian biotech company in late 2014. Soon after, we...
    The team at HaemaLogiX, together with our collaborators, is researching unique immune-based treatments to improve outcomes in patients suffering from blood cancers. The goal of these treatments is to help a patient’s immune system fight their own disease. We aim to commercialise our therapies through a series of strategic partnerships. HaemaLogiX was formed as a private Australian biotech company in late 2014. Soon after, we acquired the core proprietary technologies that are the foci of our research and development efforts to treat multiple myeloma.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HaemaLogiXAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Suite 204, 80 William Street Woolloomooloo NSW 2011
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.haemalogix.com/technology
    Linkedin
    Linkedin
    https://www.linkedin.com/company/haemalogix-pty-ltd/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HaemaLogiX Adds Former Health Minister Hunt To Board
    HaemaLogiX Adds Former Health Minister Hunt To Board

    20 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/haemalogix-welcomes-former-australian-federal-minister-for-health-professor-the-hon-greg-hunt-to-the-company-board-as-non-executive-director-302149935.html

    PR NEWSWIRE
    20 May 2024
    Share Share
    HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director
    HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director

    13 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/haemalogix-announces-appointment-of-damian-clarke-bruce-as-managing-director-and-ceo-301986694.html

    PR NEWSWIRE
    13 Nov 2023
    Share Share
    HaemaLogiX, Peter MacCallum Cancer Centre Partner on Myeloma CAR-T Trial
    HaemaLogiX, Peter MacCallum Cancer Centre Partner on Myeloma CAR-T Trial

    25 Jul 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-07-25/haemalogix-peter-maccallum-cancer-centre-partner-on-myeloma-car-t-trial/?widget=listSection

    CONTRACT PHARMA
    25 Jul 2023
    Share Share
    HaemaLogiX Announces +VE FYR from KappaMab Combination PhIIb Myeloma Trial
    HaemaLogiX Announces +VE FYR from KappaMab Combination PhIIb Myeloma Trial

    29 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/haemalogix-announces-positive-final-results-from-kappamab-combination-phase-iib-myeloma-trial-301866728.html

    PR NEWSWIRE
    29 Jun 2023
    Share Share
    HaemaLogix's myeloma drug boosts responses in Revlimid combo
    HaemaLogix's myeloma drug boosts responses in Revlimid combo

    29 Jun 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/australian-biotechs-myeloma-antibody-shows-benefits-phase-2-when-added-revlimib

    James Waldron FIERCE BIOTECH
    29 Jun 2023
    Share Share
    HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR
    HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR

    27 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/haemalogix-to-present-final-data-from-anti-kma-car-t-preclinical-studies-at-aacr-301782747.html

    PR NEWSWIRE
    27 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search